Results of a phase 1b pharmacoscintigraphic study in PD subjects have recently been published on the company website and provide proof of the pharmacokinetic principle with delayed levodopa release at the intended intervals post dosing [26]
After first use, refrigerate and discard after 28 days
Unlike many synthetic peptides, GHK-Cu exists naturally in plasma, saliva, and urine
The role of its primary antioxidant activity
We used the Human Protein Atlas and GEO database to observe NRF2 expression in various organ tissues, including skin, and found decreased NFE2L2 expression in psoriatic lesions (Fig
View Study [4]"Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting" Levolger S, Wiemer EAC, et al., 2019 Finding: LR3 IGF-I treatment effectively limited muscle mass loss in a cancer cachexia model, demonstrating its potent anti-catabolic effects and ability to preserve muscle tissue under conditions that normally cause severe muscle wasting